BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21439313)

  • 1. Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand.
    Lee BY; Assi TM; Rookkapan K; Connor DL; Rajgopal J; Sornsrivichai V; Brown ST; Welling JS; Norman BA; Chen SI; Bailey RR; Wiringa AE; Wateska AR; Jana A; Van Panhuis WG; Burke DS
    Vaccine; 2011 May; 29(21):3811-7. PubMed ID: 21439313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of changing the measles vaccine vial size on Niger's vaccine supply chain: a computational model.
    Assi TM; Brown ST; Djibo A; Norman BA; Rajgopal J; Welling JS; Chen SI; Bailey RR; Kone S; Kenea H; Connor DL; Wateska AR; Jana A; Wisniewski SR; Van Panhuis WG; Burke DS; Lee BY
    BMC Public Health; 2011 Jun; 11():425. PubMed ID: 21635774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of tailoring vial sizes to populations and locations.
    Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
    Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single versus multi-dose vaccine vials: an economic computational model.
    Lee BY; Norman BA; Assi TM; Chen SI; Bailey RR; Rajgopal J; Brown ST; Wiringa AE; Burke DS
    Vaccine; 2010 Jul; 28(32):5292-300. PubMed ID: 20566395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
    Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
    Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand.
    Lee BY; Assi TM; Rookkapan K; Wateska AR; Rajgopal J; Sornsrivichai V; Chen SI; Brown ST; Welling J; Norman BA; Connor DL; Bailey RR; Jana A; Van Panhuis WG; Burke DS
    PLoS One; 2011; 6(9):e24673. PubMed ID: 21931805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.
    Wedlock PT; Mitgang EA; Oron AP; Hagedorn BL; Leonard J; Brown ST; Bakal J; Siegmund SS; Lee BY
    Vaccine; 2019 Apr; 37(17):2356-2368. PubMed ID: 30914223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia.
    Krudwig K; Knittel B; Karim A; Kanagat N; Prosser W; Phiri G; Mwansa F; Steinglass R
    Vaccine; 2020 Aug; 38(37):5905-5913. PubMed ID: 32703746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response.
    Azam JM; Saitta B; Bonner K; Ferrari MJ; Pulliam JRC
    Vaccine; 2021 Sep; 39(40):5845-5853. PubMed ID: 34481696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery.
    Haidari LA; Wahl B; Brown ST; Privor-Dumm L; Wallman-Stokes C; Gorham K; Connor DL; Wateska AR; Schreiber B; Dicko H; Jaillard P; Avella M; Lee BY
    Vaccine; 2015 Jun; 33(28):3242-7. PubMed ID: 25889160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
    Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
    He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for measles, mumps and rubella in children.
    Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of wastage on single and multi-dose vaccine vials: Implications for introducing pneumococcal vaccines in developing countries.
    Parmar D; Baruwa EM; Zuber P; Kone S
    Hum Vaccin; 2010 Mar; 6(3):. PubMed ID: 20009517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of implementing a demand forecasting system into a low-income country's supply chain.
    Mueller LE; Haidari LA; Wateska AR; Phillips RJ; Schmitz MM; Connor DL; Norman BA; Brown ST; Welling JS; Lee BY
    Vaccine; 2016 Jul; 34(32):3663-9. PubMed ID: 27219341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh),Mozambique, and Uganda.
    Yang W; Parisi M; Lahue BJ; Uddin M; Bishai D
    Vaccine; 2014 Nov; 32(49):6643-8. PubMed ID: 25306911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.